Company profile ANIK

Anika Therapeutics Inc.
who we are we are anika therapeutics, a global medical technology company at the forefront of pain management, tissue regeneration and wound healing. we are committed to delivering innovative medical solutions that help patients feel better faster, look and feel younger and remain active. with over 7 million procedures performed over the past twenty years utilizing our propriet...ary technology, anika is helping individuals all over the world return to life naturally. our guiding principles we are innovators and creators. we value strong discipline and exceptional focus from our personnel, and we employ lean principles and agile processes in managing our business. this foundation of guiding values, combined with our entrepreneurial spirit, gives anika the ability and fortitude to generate innovative ideas and to grow our portfolio of successful products. what we do anika offers a broad spectrum of therapeutic treatments ranging from pain management and tissue regeneration to wound care an Show More
Quarter analysis & expected interestLast update: February 08 2024 14:53:05.

After 39 days of this quarter the interest is at 134.0. Based on that we can calculate that during remaining 52 days it will total up to 313.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019220
395
79.5% QoQ
477
20.8% QoQ
498
4.4% QoQ
2020 490
122.7% YoY -1.6% QoQ
184
-53.4% YoY -62.4% QoQ
273
-42.8% YoY 48.4% QoQ
140
-71.9% YoY -48.7% QoQ
2021 119
-75.7% YoY -15.0% QoQ
275
49.5% YoY 131.1% QoQ
175
-35.9% YoY -36.4% QoQ
352
151.4% YoY 101.1% QoQ
2022 217
82.4% YoY -38.4% QoQ
290
5.5% YoY 33.6% QoQ
163
-6.9% YoY -43.8% QoQ
234
-33.5% YoY 43.6% QoQ
2023 248
14.3% YoY 6.0% QoQ
270
-6.9% YoY 8.9% QoQ
431
164.4% YoY 59.6% QoQ
269
15.0% YoY -37.6% QoQ
2024 134
-46.0% YoY -50.2% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Anika Therapeutics search interestLast update: February 08 2024 14:53:05.
Correlation coefficient between keyword and revenue is -0.26
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 14:53:05.

The average 5 years interest of Anika Therapeutics was 22.43 per week.
The last year interest of Anika Therapeutics compared to the last 5 years has changed by 9.76%.
The interest for Anika Therapeutics is seasonal.
The last year interest is quite lower compared to 5 years ago. It has decreased by -29.86%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 14:53:11.

After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0.
Anika Therapeutics stock expected interest is significantly lower compared to same quarter last year (-100.0%) but similar to previous quarter.

YearQ1Q2Q3Q4
201927
117
333.3% QoQ
79
-32.5% QoQ
131
65.8% QoQ
2020 130
381.5% YoY -0.8% QoQ
260
122.2% YoY 100.0% QoQ
176
122.8% YoY -32.3% QoQ
42
-67.9% YoY -76.1% QoQ
2021 192
47.7% YoY 357.1% QoQ
36
-86.2% YoY -81.2% QoQ
295
67.6% YoY 719.4% QoQ
209
397.6% YoY -29.2% QoQ
2022 85
-55.7% YoY -59.3% QoQ
96
166.7% YoY 12.9% QoQ
150
-49.2% YoY 56.2% QoQ
62
-70.3% YoY -58.7% QoQ
2023 154
81.2% YoY 148.4% QoQ
63
-34.4% YoY -59.1% QoQ
183
22.0% YoY 190.5% QoQ
0
-100.0% YoY -100.0% QoQ
2024 0
-100.0% YoY -100.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Anika Therapeutics stock search interestLast update: February 08 2024 14:53:11.
Correlation coefficient between keyword and revenue is 0.05
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 14:53:13.

The average 5 years interest of Anika Therapeutics stock was 9.53 per week.
The last year interest of Anika Therapeutics stock compared to the last 5 years has changed by -50.37%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -36.93%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Anika Therapeutics orthopedic care to provide analysis

Correlation between past revenue and Anika Therapeutics orthopedic care search interest

There is not enough data for Anika Therapeutics orthopedic care to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Anika Therapeutics orthopedic care to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Anika Therapeutics hyaluronic acid to provide analysis

Correlation between past revenue and Anika Therapeutics hyaluronic acid search interest

There is not enough data for Anika Therapeutics hyaluronic acid to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Anika Therapeutics hyaluronic acid to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Anika Therapeutics osteoarthritis pain relief to provide analysis

Correlation between past revenue and Anika Therapeutics osteoarthritis pain relief search interest

There is not enough data for Anika Therapeutics osteoarthritis pain relief to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Anika Therapeutics osteoarthritis pain relief to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Anika Therapeutics sports medicine to provide analysis

Correlation between past revenue and Anika Therapeutics sports medicine search interest

There is not enough data for Anika Therapeutics sports medicine to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Anika Therapeutics sports medicine to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Anika Therapeutics regenerative solutions to provide analysis

Correlation between past revenue and Anika Therapeutics regenerative solutions search interest

There is not enough data for Anika Therapeutics regenerative solutions to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Anika Therapeutics regenerative solutions to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Anika Therapeutics non-orthopedic applications to provide analysis

Correlation between past revenue and Anika Therapeutics non-orthopedic applications search interest

There is not enough data for Anika Therapeutics non-orthopedic applications to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Anika Therapeutics non-orthopedic applications to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Anika Therapeutics careers to provide analysis

Correlation between past revenue and Anika Therapeutics careers search interest

There is not enough data for Anika Therapeutics careers to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Anika Therapeutics careers to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Anika Therapeutics reviews to provide analysis

Correlation between past revenue and Anika Therapeutics reviews search interest

There is not enough data for Anika Therapeutics reviews to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Anika Therapeutics reviews to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for ANIK
Earnings date: 2024-02-22 After close
Company name: Anika Therapeutics Inc.
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-04-30T20:43:11Z

GlobeNewswire
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues

2026-04-29T11:05:00Z

GlobeNewswire
Anika Reports First Quarter 2026 Financial Results

2026-04-16T11:30:00Z

GlobeNewswire
Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors

2026-04-15T20:01:00Z

GlobeNewswire
Anika to Issue First Quarter 2026 Financial Results on Wednesday, April 29, 2026

2026-04-08T22:44:20Z

GlobeNewswire
Telix Strengthens Board with Additional Director Appointments

2026-04-03T21:00:00Z

GlobeNewswire
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2026-02-26T12:05:00Z

GlobeNewswire
Anika Reports Fourth Quarter and Full Year 2025 Financial Results

2026-02-18T21:01:00Z

GlobeNewswire
Anika To Present at the Canaccord Genuity 2026 Musculoskeletal Conference

2026-02-12T21:01:00Z

GlobeNewswire
Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026

2026-02-04T08:54:00-05:00

PR Newswire
Lumicell Appoints Biotech and Medtech Leader Cheryl R. Blanchard, Ph.D., to Board of Directors

2026-01-09T13:00:39Z

Analyst Upgrades
Barrington Research Maintains Outperform on Anika Therapeutics, Maintains $16 Price Target

2026-01-08T12:00:00Z

GlobeNewswire
Anika Therapeutics Announces Leadership Transition

2025-12-30T23:00:00Z

BusinessWire
ANIK Investigation: Investors Encouraged to Contact Kirby McInerney LLP

2025-12-06T01:00:00Z

GlobeNewswire
Anika Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors ANIK

2025-11-06T20:19:59Z

Analyst Upgrades
Barrington Research Maintains Outperform on Anika Therapeutics, Raises Price Target to $16